JPMorgan raised the firm’s price target on Synovus (SNV) to $60 from $50 and keeps an Overweight rating on the shares as part of a mid- and small-cap banks earnings preview for Q2.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.